Aligos Therapeutics
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Aligos Therapeutics's balance sheet done over the years? Its assets were worth $151,527,000 last year, which is more than in the previous period. 39% of Aligos Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $59,447,000, which means an increase by 39% compared compared to last year.

Debt to Assets

Aligos Therapeutics, Inc. (NASDAQ:ALGS): Debt to assets
2018 107731000 121.47M 112.76%
2019 146520000 211.41M 144.29%
2020 265302000 45.26M 17.06%
2021 235369000 50.63M 21.51%
2022 146693000 42.79M 29.17%
2023 151527000 59.44M 39.23%

ALGS Balance Sheet (2018 – 2023)

2023 2022 2021 2020 2019 2018
Assets
Current assets:
Cash and cash equivalents
135.70M81.34M186.81M220.38M69.56M24.03M
Short term investments
044.48M3.91M23.13M48.09M66.81M
Net receivables
000000
Inventory
000000
Other current assets
5.38M7.71M13.69M5.94M2.02M1.00M
Total current assets
141.08M133.54M204.42M250.01M120.22M92.36M
Non-current assets:
Property, Plant and Equipment
9.81M12.51M14.96M14.90M16.08M15.18M
Goodwill
000000
Intangible assets
000000
Long term investments
0015.11M010.01M0
Other non-current assets
625K-2.53M866K-3.28M188K178K
Total non-current assets
10.44M13.14M30.94M15.28M26.29M15.36M
Total assets
151.52M146.69M235.36M265.30M146.52M107.73M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
1.30M9.21M7.64M7.89M6.84M3.18M
Short term debt
6.47M3.14M2.90M2.50M2.45M1.25M
Total current liabilities
23.90M33.12M38.95M30.27M13.81M7.48M
Non-current liabilities:
Long term debt
7.89M9.43M11.54M10.50M11.87M12.61M
Deferred tax
000000
Other non-current liabilities
27.64M9.66M133K14.98M185.71M101.38M
Total non-current liabilities
35.54M9.66M11.68M14.98M197.59M113.99M
Total liabilities
59.44M42.79M50.63M45.26M211.41M121.47M
Data sourceData sourceData sourceData source